Names in the News.
*Lester Crawford will be nominated by President Bush to become commissioner of the US Food and Drug Administration (FDA). Crawford, a veterinarian who holds a doctorate in pharmacology, has been acting commissioner since 2001.
*Frederick Thompson has been appointed president and CEO of the American Liver Foundation The American Liver Foundation (ALF) is a non-profit organization that promotes liver health and disease prevention. ALF provides research, education and advocacy for those affected by hepatitis and other liver diseases. The ALF has 26 chapters across the U.S. (ALF). Previously, Thompson was president and CEO of the Jane Goodall Institute The Jane Goodall Institute was founded by Jane Goodall and Genevieve, Princess di San Faustino, in 1977. In 1991, JGI launched its widest-reaching program: Roots & Shoots, a program about making positive change happen—for our communities, for animals and for the environment. in New York City.
*Retired Colonel G. Michael Fitzpatrick, PhD, has been named chief operating officer Chief Operating Officer (COO)
The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. of America's Blood Centers in Washington, DC. Fitzpatrick joined ABC in September 2003 as its chief policy officer. He served as director of the US Armed Services Blood Donor Program Office from 1999 to 2003.
*Robert Stetson McFadden, MD, has been appointed Medical Director of the Liver Disease Center at Christus Transplant Institute, Christus Santa Rosa Medical Center in San Antonio, TX. Previously, McFadden was senior transplant hepatologist at the Baylor University Medical Center Baylor University Medical Center (BUMC) is located at 3500 Gaston Avenue in east Dallas, Texas (USA). Its medical services are often listed in the annual U.S. News & World Report compilation of Best Hospitals. in Dallas.
*Paul Lacy, MD, one of the early pioneers in islet cell transplantation, passed away on February 15 in Zanesville, OH. He was 81. Dr. Lacy is recognized for his career-long research into understanding and a finding a cure for insulin-dependent diabetes. He is recognized for developing techniques to isolate and culture clusters of cells known as the islets of langerhans islets of Langerhans: see pancreas. found throughout the pancreas. At the time of his death, Dr. Lacy was chairman emeritus of the Department of Pathology, Washington University School of Medicine Washington University School of Medicine, located in St. Louis, Missouri, is one of the most competitive and highly regarded medical schools and biomedical research institutes in the United States. in St. Louis and chairman emeritus of the National Disease Research Exchange (NDRI).
Dr. Lacy was honored at a gala dinner December 1, 2004, by the NDRI.
The highlight of the evening was the awarding of the first Paul Lacy Medal to James Shapiro, MD, the highly acclaimed islet cell transplant surgeon, who is credited with developing the Edmonton Protocol.
Memorial contributions may be made to the Juvenile Diabetes Research Foundation The Juvenile Diabetes Research Foundation (JDRF) is the leading charitable funder and advocate of type 1 (juvenile) diabetes research worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. .
*Karl Robert Brinker, MD, and Paulose Mathai, MD, well-known transplant specialists at the Methodist Health System in Dallas, TX, died on January 24th in a plane crash.
Dr. Brinker, a kidney specialist, was medical director of Transplant Services at the Methodist Dallas Transplant Institute, Methodist Health System, in Dallas. He was 58. r,
Dr. Mathai, a lung transplant specialist, was section chief of Pulmonology pul·mo·nol·o·gy
The branch of medicine that deals with diseases of the respiratory system.
pulmonology The study of the lungs and respiratory function at the Methodist Dallas Medical Center, Methodist Health System. He was 50.